about
Malaysianol A, a new trimer resveratrol oligomer from the stem bark of Dryobalanops aromatica.Inhibition of prostaglandin E(2) production by synthetic minor prenylated chalcones and flavonoids: synthesis, biological activity, crystal structure, and in silico evaluation.Nordamnacanthal potentiates the cytotoxic effects of tamoxifen in human breast cancer cells.Medicinal uses, phytochemistry and pharmacology of Pongamia pinnata (L.) Pierre: a review.Acclimatisation-induced stress influenced host metabolic and gut microbial composition change.Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies.Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: a new class of β-glucuronidase inhibitors and in silico studies.Synthesis of unsymmetrical monocarbonyl curcumin analogues with potent inhibition on prostaglandin E2 production in LPS-induced murine and human macrophages cell lines.A Review of Bisindolylmethane as an Important Scaffold for Drug Discovery.5-Bromo-2-aryl benzimidazole derivatives as non-cytotoxic potential dual inhibitors of α-glucosidase and urease enzymes.Molecular hybridization conceded exceptionally potent quinolinyl-oxadiazole hybrids through phenyl linked thiosemicarbazide antileishmanial scaffolds: In silico validation and SAR studies.Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles.Synthesis of potent urease inhibitors based on disulfide scaffold and their molecular docking studies.Benzimidazole derivatives protect against cytokine-induced apoptosis in pancreatic β-Cells.Damnacanthal is a potent inducer of apoptosis with anticancer activity by stimulating p53 and p21 genes in MCF-7 breast cancer cells.2-{[2-(2-Hy-droxy-5-meth-oxy-benzyl-idene)hydrazin-1-yl-idene]meth-yl}-4-meth-oxy-phenol.Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities.UV/Visible spectra of a series of natural and synthesised anthraquinones: experimental and quantum chemical approaches.(E)-N'-(3,4-Dihy-droxy-benzyl-idene)-2,4-dimethyl-benzohydrazide monohydrate.Antiviral, cyototoxic and antimicrobial activities of anthraquinones isolated from the roots of morinda elliptica.N'-[(E)-2,3-Dihy-droxy-benzyl-idene]-2-meth-oxy-benzohydrazide.N'-[(E)-2-Hy-droxy-5-meth-oxy-benzyl-idene]-2-meth-oxy-benzohydrazide.(E)-2,4-Dimethyl-N'-(2-methyl-benzyl-idene)benzohydrazide.(E)-4-Meth-oxy-N'-(3,4,5-trihy-droxy-benzyl-idene)benzohydrazide methanol monosolvate.1,3-Dihydr-oxy-9,10-dioxo-9,10-di-hydro-anthracene-2-carbaldehyde.(E)-N'-(4-Chloro-benzyl-idene)-2-meth-oxy-benzohydrazide.2-Formyl-3-hydr-oxy-9,10-anthroquinone.3-[2-(Triphenyl-phosphanyl-idene)acet-yl]-2H-chromen-2-one.(E)-2-Meth-oxy-N'-(2,4,6-trihy-droxy-benzyl-idene)benzohydrazide.(E)-N'-(3,4-Dimeth-oxy-benzyl-idene)-4-meth-oxy-benzohydrazide.Rauniticine-allo-oxindole B methanol monosolvate.Methyl (E)-3,5-dimeth-oxy-2-{[2-(4-meth-oxy-benzo-yl)hydrazin-1-yl-idene]meth-yl}benzoate.Synthesis, in vitro α-glucosidase inhibitory activity and molecular docking studies of new thiazole derivatives.Anthraquinones with antiplasmodial activity from the roots of Rennellia elliptica Korth. (Rubiaceae).4-Phenylcoumarins from Mesua elegans with acetylcholinesterase inhibitory activity.Alkaloids from Fissistigma latifolium (Dunal) Merr.Xanthones from Garcinia mangostana (Guttiferae).Synthesis, evaluation of antioxidant activity and crystal structure of 2,4-dimethylbenzoylhydrazones.Antioxidant properties of phenolic Schiff bases: structure-activity relationship and mechanism of action.Synthesis, crystal structure, DFT studies and evaluation of the antioxidant activity of 3,4-dimethoxybenzenamine schiff bases.
P50
Q34165980-AE4F5000-5D22-4C48-A2E1-813E2D586700Q34429241-DBB674A0-A43F-4036-B508-DD6DB285D9EEQ34583778-6160EE9A-9D76-4AF1-9580-88CFEEEB219EQ34982263-8F8B10C5-4021-402C-8D59-5E8531A28B17Q35405811-857F5AB0-38CD-48B3-9E8C-12E8DFA1ABF2Q35542186-1392049E-E2BF-435F-B6C7-67C33F329A05Q35639561-21E17CF8-FB69-48FD-B210-2BA6BBDD210FQ35978487-EA5C178C-AA99-41F6-B2B6-E463BC418E29Q38599632-6E76ACC7-883B-439B-8376-2F46EC5A510AQ38710271-01B71690-9223-466E-B882-567F53E5BB97Q38715357-C42A7870-1978-43CD-910E-4AA8EC30D547Q38792705-B236B4CE-B69F-4C58-A67C-5DF19F39071FQ38824377-C205CF97-9447-41FC-8197-275E6BE9B490Q38838785-72A490FF-AD3C-4F5F-8B0A-608375EA3650Q38932426-24947349-21FC-4063-B00B-EC78CA7B8342Q38943291-6B31587F-CB63-41AE-9004-0E74295F64FCQ38971046-771B1933-D7C2-4F55-8EFD-EF200E1F28A8Q39805900-059B3B55-1D5F-4BDC-A50D-EB728D914EBAQ39925220-052DEEEB-B5B6-4883-9790-7ADF3FC9B428Q40909225-2C156C81-C9A4-4EAF-87F7-1F83D6985E2CQ41587718-8EF9C3F7-AEA1-4293-B3FC-23EE375081DFQ41587762-53A79EE5-F68E-4F52-8959-EEC4FD738460Q41599977-0683484D-7033-4474-90E9-C1A4D83612F8Q41824633-A3142AFE-51F5-4EB9-B13C-BBEE57C3F525Q41833508-3B3AE839-25D3-4048-9CB5-2BB37A45B2D3Q41888175-68A67390-71D0-4136-A17F-D7631AADE5A8Q41914033-1838B267-9715-45D7-8014-3665814B9517Q42014911-D2B98565-52E3-45B5-B77D-8092E8D63540Q42078932-3CDF1CB1-434D-4A56-B7D2-063E586EEB45Q42129777-99DAC55B-874A-4FB4-B066-2339D9A18665Q42209237-47DF0082-F150-4DA2-9D0A-886FB078D17BQ42323536-00BCDD52-E544-4E59-A541-4CBDB1BC887CQ42807571-5BD1DBFA-1BDC-4741-9413-962F6EB28F1BQ42850753-3F11B8A4-53B6-41EA-B5E4-973A092F8D9BQ42860066-AC15901D-E6E5-431C-B32E-D61B5601609AQ42958889-67CCA39D-6765-44F4-B2F3-968F9834CD5EQ43033984-D63C7E4A-3873-49F7-BB32-5D7D2B142AFEQ44042957-85FDF6B8-E87F-4122-8271-14BEC93F9FC6Q44319409-FE31584C-BEE5-4C10-9D96-37F9B3755DFCQ44678177-A925EBE3-E67A-4A59-99EE-558AA5A20C3E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nor Hadiani Ismail
@ast
Nor Hadiani Ismail
@en
Nor Hadiani Ismail
@es
Nor Hadiani Ismail
@nl
Nor Hadiani Ismail
@sl
type
label
Nor Hadiani Ismail
@ast
Nor Hadiani Ismail
@en
Nor Hadiani Ismail
@es
Nor Hadiani Ismail
@nl
Nor Hadiani Ismail
@sl
prefLabel
Nor Hadiani Ismail
@ast
Nor Hadiani Ismail
@en
Nor Hadiani Ismail
@es
Nor Hadiani Ismail
@nl
Nor Hadiani Ismail
@sl
P108
P106
P1960
YybPYjIAAAAJ
P2038
Nor_Ismail2
P31
P496
0000-0002-2374-4630
P569
2000-01-01T00:00:00Z